Gentian Diagnostics: Key information relating to the proposed cash dividend

Moss, 12 February 2026

The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per
share, based on the company's financial statements for the financial year 2025,
to the General Meeting.

Dividend amount:               0.60 per share
Announced currency:        Norwegian krone (NOK)
Last day including right:   5 May 2026
Ex-date:                               6 May 2026
Record date:                       7 May 2026
Payment date:                    from 18 May 2026
Date of approval:               5 May 2026


For further information, please contact:

Njaal Kind, CFO
njaal.kind@gentian.no
+47 919 06 525 (mobile)

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.